t
ECO Animal Health Group plc granted deferred nominal cost share options on 21 December 2023 under its Deferred Bonus Plan to two Executive Directors. CEO David Hallas received 26,985 options and CFO Chris Wilks received 17,577 options, totaling 44,562 ordinary shares. These awards, representing approximately 0.07% of the Company's issued share capital, relate to the deferral of 33% of their annual bonus for the financial year ended 31 March 2023 and vest after 3 years.
| Date | 22 Dec 2023 |
| Time | 07:00:06 |
| Category | Director/PDMR dealings |
| ID | 6822X |
22 December 2023
ECO Animal Health Group plc
("ECO" or the "Company")
Deferred Share Option Awards to Executive Directors
ECO Animal Health Group plc announces that on 21 December 2023 deferred nominal cost share options were granted under the Company's Deferred Bonus Plan ("DBS") over 44,562 ordinary shares in the Company (representing approximately 0.07 percent of the Company's issued share capital) to two Executive Directors listed below. These awards relate to the deferral of 33% of the annual bonus for Executive Directors earned in respect of the Company's financial year ended 31 March 2023.
|
Name |
Position |
Number of Deferred Share Options |
|
David Hallas |
Chief Executive Officer |
26,985 |
|
Chris Wilks |
Chief Financial Officer |
17,577 |
As indicated in the Circular to shareholders dated 4 February 2021, the DBS has been established to allow the Remuneration Committee to require a significant part of the annual bonuses paid to Executive Directors to be deferred in exchange for an award of nominal cost options which vest after 3 years.
For further information please contact:
|
|
||||||||
|
|
|
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.
PDMR Notification - ECO DBS Deferred Share Option Awards
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
|
a. |
Name |
1. David Hallas 2. Chris Wilks
|
||||||
|
2. |
Reason for the notification |
|||||||
|
a. |
Position/status |
1. Chief Executive Officer 2. Chief Financial Officer
|
||||||
|
b. |
Initial notification /Amendment |
Initial notification |
||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a. |
Name |
Eco Animal Health Group Plc |
||||||
|
b. |
LEI |
2138009XN9DJ3YP70B55 |
||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a. |
Description of the Financial instrument, type of instrument Identification code |
Options over ordinary shares of 5p each.
GB0032036807
|
||||||
|
b. |
Nature of the transaction |
Award of nominal cost share options under the Company's DBS. |
||||||
|
c. |
Price(s) and volume(s) |
Numbers 1 to 7 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
|
||||||
|
d. |
Aggregated information Aggregated volume Price
|
n/a
|
||||||
|
e. |
Date of the transaction |
21 December 2023 |
||||||
|
f. |
Place of the transaction |
Outside a trading venue.
|
||||||